He discusses his latest analysis of IMPROVE-IT data, which compared simvastatin-ezetimibe combination therapy with simvastatin monotherapy among patients aged 75 years or older who had had acute coronary...
In this podcast, Laurence Sperling, MD, from Emory University School of Medicine, explains the newest ACC/AHA cholesterol guidelines, the top 10 take-home messages for cardiologists, and the lessons learned...
In part 4 of our series on lipid management, Paul Jellinger, MD, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of...
In this commentary, Dr Seth Martin explains the updates to the Friedewald estimation that he hopes more labs will adopt to ensure LDL assessments are as accurate as possible.
With increasing application of AI to health care, there is often concern that AI will replace clinicians. However, there is opportunity to optimize this partnership to improve patient care.
In this podcast, Seth Martin, MD, from Johns Hopkins University School of Medicine, discusses his research on the direct method of estimating low-density lipoprotein cholesterol and how to better use...
Samarth P. Shah, PharmD, and Timothy H. Self, PharmD
Samarth P. Shah, PharmD, and Timothy H. Self, PharmD
A patient’s response to warfarin is affected by several factors such as the use of other drugs, disease states, age, dietary vitamin K, and genetic poymorphisms.
David Sabgir, MD, FACC, of Mount Carmel Health Systems, talks about the dangers of very high tryglicerides and offers several tips on how physicians can help their patients manage healthy triglyceride...
